US 12,102,789 B1
Radiopharmaceutical delivery system and use thereof for patient infusion
James A. Kaufman, Montreal (CA); Dominic Siewko, Kirkland (CA); and Indranil Nandi, Yardley, PA (US)
Assigned to Jubilant Draximage Inc., (CA)
Filed by Jubilant Draximage Inc., Montreal (CA)
Filed on Mar. 27, 2024, as Appl. No. 18/618,798.
Claims priority of provisional application 63/492,628, filed on Mar. 28, 2023.
Int. Cl. A61M 5/142 (2006.01); A61M 5/168 (2006.01); A61M 5/178 (2006.01); G16H 10/60 (2018.01); G16H 40/63 (2018.01)
CPC A61M 5/142 (2013.01) [A61M 5/16831 (2013.01); A61M 5/1785 (2013.01); G16H 10/60 (2018.01); G16H 40/63 (2018.01); A61M 2005/14208 (2013.01); A61M 2005/16863 (2013.01); A61M 2202/0007 (2013.01); A61M 2202/049 (2013.01); A61M 2205/10 (2013.01); A61M 2205/18 (2013.01); A61M 2205/3327 (2013.01); A61M 2205/3331 (2013.01); A61M 2205/3379 (2013.01); A61M 2205/502 (2013.01); A61M 2205/584 (2013.01); A61M 2205/6009 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A radiopharmaceutical drugs delivery system comprising:
(i) a movable cart with an integrated handle;
(ii) an informatics system with a computer screen configured as a graphical user interface (GUI);
(iii) an infusion pump; and
(iv) a configurable dose transporter, wherein the configurable dose transporter comprises:
a) a separable radioactive dose transportation and containment module;
b) a shielding for use with one or more of different radionuclide types, quantities and volume;
c) a radioactive dose in a syringe or a vial; and
d) a disposable sealed fluid cartridge connected to the syringe or a vial via a compression fitting.